期刊文献+

细胞工厂在乙型脑炎减毒活疫苗生产中的应用

Application of cell factory in production of live attenuated Japanese encephalitis vaccine
原文传递
导出
摘要 目的采用40层细胞工厂(CF40)替代15 L转瓶工艺制备乙型脑炎(乙脑)减毒活疫苗。方法分别采用CF40和15 L转瓶工艺制备乙脑减毒活疫苗.通过显微镜观察和细胞计数来考察细胞质量。病毒收获时观察细胞病变情况,并对2种工艺制备的原液、半成品以及成品进行病毒滴度检测对比,成品37℃放置7d考察成品热稳定性。结果两种工艺相比,CF40细胞密度高于15L转瓶,差异有统计学意义(F=10.60,P<0.05),生长一致性和单只地鼠制备的细胞数量也均优于15L转瓶;CF40和15 L转瓶制备的单一病毒收获液平均滴度分别为7.59和7.56 lg噬斑形成单位/ml,差异无统计学意义(F=0.63,P>0.05),但CF40单一病毒收获液收率一致性更好;两种工艺制备的原液、半成品、成品滴度以及7 d后37℃热稳定性均符合企业注册标准规定。结论使用CF40制备乙脑减毒活疫苗是可行的,并且在产品收率和一致性方面优于15 L转瓶工艺。 Objective To prepare live attenuated Japanese encephalitis vaccine(JEV)by 40-layer cell factory(CF40)instead of 15 L rolling bottle.Methods JEV was prepared by CF40 and 15 L rolling bottle separately.Cell quality was checked by microscope and cell counting.Growth of cells was observed when virus was harvested.Virus titers of the bulk,final bulk and final product prepared by two processes were compared.The thermal stability of the final product was investigated after being placed at 37℃for 7 days.Results Between two processes,the cell density in CF40 was significantly higher than that in 15 L rolling bottle(F=10.60,P<0.05).The growth consistency and the number of cells prepared per hamster were better in CF40.The average virus titers of single harvest solutions from CF40 and 15 L rolling bottle were 7.59 and 7.56 lg plaque-forming unit/ml,respectively,with no significant difference(F=0.63,P>0.05),but the yield of CF40 single virus harvested solution was more consistent.The titers of the bulk,final bulk and final product prepared by the two processes,and the thermal stability at 37℃after 7 days of final product all met the provisions of enterprise registration standards.Conclusion It is feasible to prepare live attenuated JEV by CF40,and its yield and consistency of product are better than those of 15 L rolling bottle.
作者 王玖强 刘少祥 周卫 侯良玉 金鹏 李军 李挺 郭红 田志航 张莹 Wang Jiuqiang;Liu Shaoxiang;Zhou Wei;Hou Liangyu;Jin Peng;Li Jun;Li Ting;Guo Hong;Tian Zhihang;Zhang Ying(Viral Vaccine DivisionⅠ,Chengdu Institute of Biological Products Co.,Ltd.,Sichuan Engineering Technology Research Center of Vaccines,Chengdu 610023,China;Chengdu Institute of Biological Products Co.,Ltd.,Chengdu 610023,China)
出处 《国际生物制品学杂志》 CAS 2021年第6期301-304,共4页 International Journal of Biologicals
基金 国家科技重大专项"重大新药创制"(2014ZX09304316)。
关键词 乙型脑炎减毒活疫苗 细胞工厂 转瓶 工艺优化 Japanese encephalitis vaccine Cell factory Rolling bottle Process optimization
  • 相关文献

参考文献7

二级参考文献106

  • 1王晓军,张彦平,张荣珍,陈圆生,梁晓峰.中国1998~2002年流行性乙型脑炎流行趋势分析[J].中国计划免疫,2004,10(4):215-217. 被引量:76
  • 2王环宇,付士红,李晓宇,宋宏,闵继光,邓娟,杨益良,Ichiro Kurane,梁国栋.我国首次分离到基因Ⅰ型乙型脑炎病毒[J].中华微生物学和免疫学杂志,2004,24(11):843-849. 被引量:79
  • 3孙肖红,付士红,张海林,王环宇,何英,刘卫滨,杨卫红,冯云,闽继光,韩瑞红,梁国栋.云南省虫媒病毒的分离鉴定[J].中华实验和临床病毒学杂志,2005,19(4):319-324. 被引量:37
  • 4姜典才,徐丽洁,林朝霞,张洁,陈玉琴,李凤祥.对我国生物制品批签发工作的几点思考[J].中国药事,2006,20(3):147-148. 被引量:3
  • 5王俊文,付士红,王环宇,毛晓燕,刘卫滨,何英,孙肖红,蔡增林,吴立平,赵习芳,韩瑞红,景雅,梁国栋.辽宁省乙脑病毒的分离与鉴定[J].中华实验和临床病毒学杂志,2006,20(1):61-65. 被引量:40
  • 6卫生部办公厅,国家食品药品监督管理局办公室.全国疑似预防接种异常反应监测方案[S].2010-06-03.
  • 7World Health Organization. Vaccine-preventable diseases and immunization [EB/OL]. (2010-05-21) [2015-06-12]. http:// www.euro.who.int/vaccine/2008121711.
  • 8WHO. Immunization Safety Surveillance Guidelines for immunization programme managers on surveillance of adverse events following immunization [M]. 2nd ed. Manila, Philippines: WHO Regional Office for the Western Pacific, 2013.
  • 9Chatterjee A, O' Keefe C. Current controversies in the USA regarding vaccine safety [J]. Expert Rev Vaccines 2010, 9 (5) :497-502. DOI: 10.1586/erv.10.36.
  • 10Bonhoeffer J, Black S, Lzurieta H, et al. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe [J]. Biologicals, 2012, 40 (5) : 393- 397. DOI: 10.1016/j.biologicals.2012.07.007.

共引文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部